Second success in licensing Drug Delivery Technology by our Australian client

Published : 04 Apr 2012


Today our Melbourne based publicly listed client received their second success in Out-licensing their drug delivery technology for 3 anti-aging formulations to a large Indian Pharma company.

Indian company officials said that it will leverage their substantial existing pharmaceutical marketing and sales infrastructure that covers dermatologists and general physicians, to launch this new product line. Australian company CEO said the latest Indian agreement was another milestone in the company's commercial strategy to roll out its personal care products globally. She said India, with a population of over 1.2 billion people represented a large scale market opportunity for her company.

They are expected to launch a full dermatological line of personal care products in India if the first three products are a success.


×
Twitter